Purchase Order 75N98026P01157

The National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) awarded a purchase order to Transnetyx, Inc. valued at $772,860.15 on July 17, 2020, for DNA extraction and multi-gene analysis services on rodent tissue samples. No set-aside applied. Work is performed in Bethesda, Maryland. The order exercised Option 4 under a firm fixed-price purchase order structure with an ultimate completion date of July 16, 2025. SCI reporting for fiscal year 2022 captured 471 FTEs across...

The National Institute on Aging issued a $336,870 delivery order to Transnetyx, Inc. on April 4, 2026, under the NIA Genotyping Outsourcing Project indefinite delivery contract for base-year genotyping services. The parent NIA Genotyping Outsourcing Project is a $1,465,680 indefinite delivery contract covering DNA extraction, multi-gene analysis of rodent tissue samples, and database posting of results. Place of performance is Cordova, TN. The order is firm fixed price with an ultimate...

This is a firm fixed-price purchase order awarded by the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), a civilian agency within the U.S. Department of Health and Human Services, to Transnetyx, Inc., a for-profit organization specializing in genetic testing and analysis services. The contract, valued at $147,260.00, is for the provision of genotyping services for rodent samples to support the NIAMS intramural research program. The contract does not have a...

Transnetyx, Inc. was awarded a $23,926.20 firm fixed price Blanket Purchase Agreement (BPA) call by the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), a civilian agency within the National Institutes of Health, on February 14, 2020, with completion scheduled for October 31, 2020. The award was made through open market competition with no set-aside designation. Transnetyx, headquartered in Cordova, Tennessee, is a specialized provider of advanced genetic testing...

Transnetyx, Inc., headquartered in Cordova, Tennessee, received a $24,625 firm fixed price Blanket Purchase Agreement call from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), a component of the National Institutes of Health under the Department of Health and Human Services. The award, issued on August 28, 2019, with an ultimate completion date of August 27, 2020, was not set aside for any particular business category and represents services to be performed...

The National Human Genome Research Institute awarded a $24,990.75 firm fixed-price purchase order to Transnetyx, Inc. for automated genotyping services under the FY26 Unobligated Dollar (UDO) Initiative. The contract, awarded on June 3, 2024, with a completion date of March 1, 2025, will be performed at Transnetyx's location in Bethesda, Maryland. This procurement represents part of the government's efforts to utilize remaining fiscal year 2026 funding and carries no set-aside designation,...

The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), a civilian agency within the U.S. Department of Health and Human Services, awarded a $15,000.00 firm fixed-price purchase order to Transnetyx, Inc., a for-profit organization based in Cordova, Tennessee. The contract is for genotyping services to identify the genotypes of NIDA-bred rodents. This award is not set-aside and represents an open market competition. Transnetyx, Inc. is a key provider of genetic testing...

This is a firm fixed-price Blanket Purchase Agreement (BPA) call contract awarded to Transnetyx, Inc., a for-profit organization based in Cordova, Tennessee, by the National Institute of Neurological Disorders and Stroke (NINDS), a component of the National Institutes of Health (NIH) within the U.S. Department of Health and Human Services. The contract is for $10,000.00 and provides custom mouse genotyping services to determine the genotype of newly born mice, as only mice with specific...

This firm-fixed-price federal contract award to Transnetyx, Inc. for $2,985 provides genotyping services to the National Institute of Neurological Disorders and Stroke (NINDS), a component of the National Institutes of Health (NIH). The contract has a period of performance ending on July 24, 2025. Transnetyx, a for-profit organization specializing in automated genotyping, has established itself as a key provider of DNA extraction, gene analysis, and genotyping services for NIH research on...

This is a federal contract awarded by the National Institute on Drug Abuse (NIDA), a component of the U.S. Department of Health and Human Services, to Transnetyx, Inc., a for-profit organization headquartered in Cordova, Tennessee. The contract has a ceiling value of $117,136.20 and was awarded on a firm-fixed-price basis. It is not designated as a set-aside contract. The contract provides for Transnetyx to deliver automated genotyping, DNA extraction, multi-gene analysis, and bioinformatics...